The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level

被引:3
|
作者
Chu, Zhili [1 ,2 ]
Yang, Sihui [1 ]
Li, Qianru [1 ]
Shang, Jianing [1 ]
Ren, Zilong [1 ]
Ren, Feng [1 ,2 ]
机构
[1] Xinxiang Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Xinxiang Key Lab Pathogen Biol, Xinxiang, Peoples R China
[2] Xinxiang Med Univ, Henan Int Joint Lab Immun & Targeted Therapy liver, Xinxiang, Peoples R China
关键词
Newcastle disease virus; V protein; Cell proliferation; MAPK signaling pathway; WNT signaling pathway;
D O I
10.1186/s12885-023-10815-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundNewcastle disease virus (NDV) is an oncolytic virus that can inhibit cancer cell proliferation and kill cancer cells. The NDV nonstructural V protein can regulate viral replication; however, whether the V protein contributes to NDV oncolysis is unclear.ResultsThis study revealed that NDV inhibited tumor cell proliferation and that V protein expression promoted the proliferation of HepG2 cells, as determined at the single-cell level. In addition, to identify the regulatory mechanism of the V protein in HepG2 cells, transcriptome sequencing was performed and indicated that the expression/activation of multiple cell proliferation-related genes/signaling pathways were changed in cells overexpressing the V protein. Hence, the MAPK and WNT signaling pathways were selected for verification, and after blocking these two signaling pathways with inhibitors, the V protein promotion of cell proliferation was found to be attenuated.ConclusionsThe results showed that the V protein regulated the proliferation of cancer cells through multiple signaling pathways, providing valuable references for future studies on the mechanism by which the V protein regulates cancer cell proliferation.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Iron regulation of transferrin synthesis in the human hepatoma cell line HepG2
    Barnum-Huckins, K
    Adrian, GS
    CELL BIOLOGY INTERNATIONAL, 2000, 24 (02) : 71 - 77
  • [32] Cultivation of hepatoma cell line HepG2 on nanoporous aluminum oxide membranes
    Hoess, A.
    Teuscher, N.
    Thormann, A.
    Aurich, H.
    Heilmann, A.
    ACTA BIOMATERIALIA, 2007, 3 (01) : 43 - 50
  • [33] HBSAG INTERACTION WITH AND PROCESSING BY THE HUMAN HEPATOMA-CELL LINE HEPG2
    KAISER, J
    STOCKERT, RJ
    SCHEIN, PS
    WOLKOFF, AW
    HEPATOLOGY, 1986, 6 (05) : 1200 - 1200
  • [34] Genomic comparison of insecticides and herbicide in human hepatoma (HepG2) cell line
    Yu Ri An
    Seung-Jun Kim
    Hey-Won Park
    Moon-Ju Oh
    Youn-Jung Kim
    Jae-Chun Ryu
    Seung Yong Hwang
    Molecular & Cellular Toxicology, 2010, 6 : 378 - 383
  • [35] In Vivo Imaging of Oncolytic Measles Virus Propagation with Single-Cell Resolution
    Kemler, Iris
    Ennis, Matthew K.
    Neuhauser, Claudia M.
    Dingli, David
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 12 : 68 - 78
  • [36] Cell cycle perturbation in HepG2 cell line constitutively expressing Hepatitis C virus core protein
    Ruggieri, A
    Franco, M
    Gatto, I
    Harada, T
    Miyamura, T
    Rapicetta, M
    2ND EUROPEAN CONGRESS OF VIROLOGY, PROCEEDINGS, 2004, : 41 - 45
  • [37] REGULATION OF CELL-PROLIFERATION BY HORMONES AND LIVER-SPECIFIC GROWTH-FACTORS IN THE HUMAN HEPATOMA-CELL LINE, HEPG2
    FLEIG, WE
    HOSS, G
    DITSCHUNEIT, H
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1986, 24 (09): : 563 - 563
  • [38] Effects of the downregulation of SnoN expression on HepG2 cell proliferation and apoptosis
    Wang, Wenqi
    Liu, Changhong
    Wang, Yiguo
    Cao, Lili
    MOLECULAR MEDICINE REPORTS, 2013, 7 (04) : 1324 - 1328
  • [39] Annphenone from Artemisia vestita Inhibits HepG2 Cell Proliferation
    Long, Anhua
    Fu, Jie
    Hu, Yang
    Luo, Yin
    ASIAN JOURNAL OF CHEMISTRY, 2013, 25 (17) : 9497 - 9502
  • [40] Cell-Type-Specific Innate Immune Response to Oncolytic Newcastle Disease Virus
    Biswas, Moanaro
    Kumar, Sandeep R. P.
    Allen, Adria
    Yong, Wang
    Nimmanapalli, Ramadevi
    Samal, Siba K.
    Elankumaran, Subbiah
    VIRAL IMMUNOLOGY, 2012, 25 (04) : 268 - 276